Algiax
Erkrath, DE · 1 known investors
Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need. The company's lead candidate AP-325 is in Phase 2 clinical trials for chronic neuropathic pain.
Founders & leadership
DG
Dr. Guido KoopmansChief Scientific Officer
DB
Dr. Birgit HasseHead of CMS and Regulator Affairs
Investors · 1
In the news
Frequently asked questions
- What does Algiax do?
- Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need. The company's lead candidate AP-325 is in Phase 2 clinical trials for chronic neuropathic pain.
- Who are Algiax's investors?
- Algiax's investors include OCCIDENT.
- Where is Algiax headquartered?
- Algiax is headquartered in Erkrath, DE.